BIOMAT Database Logo BIOMAT Database Logo

Gender differences in the phenotypic expression of Alzheimer's disease in Down's syndrome (trisomy 21). 1994

R Raghavan, and C Khin-Nu, and A G Brown, and K A Day, and S P Tyrer, and P G Ince, and E K Perry, and R H Perry
Department of Neuropathology, Newcastle General Hospital, Newcastle upon Tyne, UK.

Twenty-eight individuals with typical Down's syndrome (DS) phenotype (17 males and 11 females; age range: 10-74 years) were investigated for gender differences in the phenotypic expression of Alzheimer-type pathology (ATP). Quantitative neuropathology was performed in the 4 neocortical lobes of the right hemisphere, by counting senile plaques (SP), and neurofibrillary tangles (NFT). ATP was present in 25 middle-aged (> 40 years) individuals (16 males and 9 females). Females had significantly higher (p = 0.03) mean neocortical NFT densities (36.6 per mm2; s.e.m. +/- 6.6) than males (17.9 per mm2; s.e.m. +/- 4.7). None of the females had NFT densities below 10 per mm2, compared with 6 males in whom NFT were either absent or seen in very low densities (< 4 per mm2). Assessment of SP densities in the same cortical regions showed non-significant differences in females (42.4 per mm2; s.e.m. +/- 5.1) compared with males (33.6 per mm2; s.e.m. +/- 2.1). There was clinical evidence of dementia in all the female (8/8) individuals who were prospectively assessed, compared with only 54% (7/13) of males. The male individuals without clinical dementia had absent or low neocortical NFT densities regardless of high SP densities. Female DS cases (mean age: 48.8 years; s.e.m. +/- 1.9) had an earlier onset of dementia than males (mean age: 53.6 years; s.e.m. +/- 1.3; p = 0.05). Female middle-aged DS individuals have an earlier onset, and a more severe form of AD which correlates with higher neocortical NFT rather than SP density.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004314 Down Syndrome A chromosome disorder associated either with an extra CHROMOSOME 21 or an effective TRISOMY for chromosome 21. Clinical manifestations include HYPOTONIA, short stature, BRACHYCEPHALY, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, single transverse palmar crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213) Mongolism,Trisomy 21,47,XX,+21,47,XY,+21,Down Syndrome, Partial Trisomy 21,Down's Syndrome,Partial Trisomy 21 Down Syndrome,Trisomy 21, Meiotic Nondisjunction,Trisomy 21, Mitotic Nondisjunction,Trisomy G,Downs Syndrome,Syndrome, Down,Syndrome, Down's
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000255 Adenosine Triphosphate An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter. ATP,Adenosine Triphosphate, Calcium Salt,Adenosine Triphosphate, Chromium Salt,Adenosine Triphosphate, Magnesium Salt,Adenosine Triphosphate, Manganese Salt,Adenylpyrophosphate,CaATP,CrATP,Manganese Adenosine Triphosphate,MgATP,MnATP,ATP-MgCl2,Adenosine Triphosphate, Chromium Ammonium Salt,Adenosine Triphosphate, Magnesium Chloride,Atriphos,Chromium Adenosine Triphosphate,Cr(H2O)4 ATP,Magnesium Adenosine Triphosphate,Striadyne,ATP MgCl2

Related Publications

R Raghavan, and C Khin-Nu, and A G Brown, and K A Day, and S P Tyrer, and P G Ince, and E K Perry, and R H Perry
[Down's syndrome. Trisomy 21].
March 1968, Revista clinica espanola,
R Raghavan, and C Khin-Nu, and A G Brown, and K A Day, and S P Tyrer, and P G Ince, and E K Perry, and R H Perry
Down's Syndrome (Mongolism, Trisomy 21).
May 1972, The American journal of pathology,
R Raghavan, and C Khin-Nu, and A G Brown, and K A Day, and S P Tyrer, and P G Ince, and E K Perry, and R H Perry
[Down's syndrome. Mongolism, trisomy 21].
April 1971, Ugeskrift for laeger,
R Raghavan, and C Khin-Nu, and A G Brown, and K A Day, and S P Tyrer, and P G Ince, and E K Perry, and R H Perry
[Epidemiology of Down's syndrome (trisomy 21)].
December 1980, Ceskoslovenska pediatrie,
R Raghavan, and C Khin-Nu, and A G Brown, and K A Day, and S P Tyrer, and P G Ince, and E K Perry, and R H Perry
Chromosome 21, Down's syndrome and Alzheimer's disease.
June 1987, Journal of mental deficiency research,
R Raghavan, and C Khin-Nu, and A G Brown, and K A Day, and S P Tyrer, and P G Ince, and E K Perry, and R H Perry
Alzheimer's disease, Down's syndrome, and chromosome 21.
May 1987, Lancet (London, England),
R Raghavan, and C Khin-Nu, and A G Brown, and K A Day, and S P Tyrer, and P G Ince, and E K Perry, and R H Perry
[Mongolism (Down's syndrome or trisomy 21)].
January 1981, Stomatologia,
R Raghavan, and C Khin-Nu, and A G Brown, and K A Day, and S P Tyrer, and P G Ince, and E K Perry, and R H Perry
Craniofacial complex in the trisomy 21 syndrome (Down's syndrome).
July 1971, Archives of oral biology,
R Raghavan, and C Khin-Nu, and A G Brown, and K A Day, and S P Tyrer, and P G Ince, and E K Perry, and R H Perry
Trisomy 21 Down's syndrome in three siblings.
May 1979, New York state journal of medicine,
R Raghavan, and C Khin-Nu, and A G Brown, and K A Day, and S P Tyrer, and P G Ince, and E K Perry, and R H Perry
Infantile glaucoma in Down's syndrome (trisomy 21).
April 1988, American journal of ophthalmology,
Copied contents to your clipboard!